Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

A Survey Study of Female Radiation Oncology Residents' Experiences to Inform Change.

Osborn VW, Doke K, Griffith KA, Jones R, Lee A, Maquilan G, Masters AH, Albert AA, Dover LL, Puckett LL, Hentz C, Kahn JM, Colbert LE, Barry PN, Jagsi R.

Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):999-1008. doi: 10.1016/j.ijrobp.2019.05.013. Epub 2019 May 17.

PMID:
31108141
2.

Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.

Fujimoto TN, Colbert LE, Huang Y, Molkentine JM, Deorukhkar A, Baseler L, de la Cruz Bonilla M, Yu M, Lin D, Gupta S, Cabeceiras PK, Kingsley CV, Tailor RC, Sawakuchi GO, Koay EJ, Piwnica-Worms H, Maitra A, Taniguchi CM.

Cancer Res. 2019 May 1;79(9):2327-2338. doi: 10.1158/0008-5472.CAN-18-1785.

PMID:
31043430
3.

Brachytherapy Training Survey of Radiation Oncology Residents.

Marcrom SR, Kahn JM, Colbert LE, Freese CM, Doke KN, Yang JC, Yashar CM, Luu M, Kamrava M.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):557-560. doi: 10.1016/j.ijrobp.2018.10.023. Epub 2018 Oct 26.

PMID:
30612963
4.

Dose escalation for locally advanced pancreatic cancer: How high can we go?

Colbert LE, Rebueno N, Moningi S, Beddar S, Sawakuchi GO, Herman JM, Koong AC, Das P, Holliday EB, Koay EJ, Taniguchi CM.

Adv Radiat Oncol. 2018 Oct 23;3(4):693-700. doi: 10.1016/j.adro.2018.07.008. eCollection 2018 Oct-Dec.

5.

Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer.

Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):593-600. doi: 10.1016/j.ijrobp.2018.06.404. Epub 2018 Jul 12.

PMID:
30017792
6.

Top 10 Tips Palliative Care Clinicians Should Know About Radiation Oncology.

Dharmarajan KV, Rich SE, Johnstone CA, Hertan LM, Wei R, Colbert LE, Jones JA, Kamal AH, Jones CA.

J Palliat Med. 2018 Mar;21(3):383-388. doi: 10.1089/jpm.2018.0009. Epub 2018 Feb 12.

7.

Outcomes of ICU Admission of Patients With Progressive Metastatic Gastrointestinal Cancer.

Epstein AS, Yang A, Colbert LE, Voigt LP, Meadows J, Goldberg JI, Saltz LB.

J Intensive Care Med. 2017 Jan 1:885066617748874. doi: 10.1177/0885066617748874. [Epub ahead of print]

8.

Author's Response.

Desai AV, Epstein AS, Colbert LE, Saltz LB.

J Pain Symptom Manage. 2018 Jan;55(1):e2-e3. doi: 10.1016/j.jpainsymman.2017.11.003. Epub 2017 Nov 13. No abstract available.

PMID:
29146195
9.

Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC.

Colbert LE, Moningi S, Chadha A, Amer A, Lee Y, Wolff RA, Varadhachary G, Fleming J, Katz M, Das P, Krishnan S, Koay EJ, Park P, Crane CH, Taniguchi CM.

Adv Radiat Oncol. 2017 Mar 18;2(3):403-415. doi: 10.1016/j.adro.2017.02.004. eCollection 2017 Jul-Sep.

10.

Discharge to Subacute Rehabilitation Facilities Does Not Benefit Patients Hospitalized With Progressive Gastrointestinal Cancer.

Desai AV, Epstein AS, Colbert LE, Saltz LB.

J Pain Symptom Manage. 2017 Aug;54(2):e4-e7. doi: 10.1016/j.jpainsymman.2017.03.006. Epub 2017 Apr 22. No abstract available.

PMID:
28438586
11.

Palliative care and palliative radiation therapy education in radiation oncology: A survey of US radiation oncology program directors.

Wei RL, Colbert LE, Jones J, Racsa M, Kane G, Lutz S, Vapiwala N, Dharmarajan KV.

Pract Radiat Oncol. 2017 Jul - Aug;7(4):234-240. doi: 10.1016/j.prro.2016.11.009. Epub 2016 Dec 1.

PMID:
28222994
12.

Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second-stage hepatectomy.

Colbert LE, Cloyd JM, Koay EJ, Crane CH, Vauthey JN.

Surgery. 2017 Jun;161(6):1543-1548. doi: 10.1016/j.surg.2016.11.034. Epub 2017 Jan 9. Review.

PMID:
28081954
13.

TNFRSF10C copy number variation is associated with metastatic colorectal cancer.

Tanenbaum DG, Hall WA, Colbert LE, Bastien AJ, Brat DJ, Kong J, Kim S, Dwivedi B, Kowalski J, Landry JC, Yu DS.

J Gastrointest Oncol. 2016 Jun;7(3):306-14. doi: 10.21037/jgo.2015.11.04.

14.

Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas.

Seldon CS, Colbert LE, Hall WA, Fisher SB, Yu DS, Landry JC.

World J Gastrointest Oncol. 2016 Apr 15;8(4):358-65. doi: 10.4251/wjgo.v8.i4.358. Review.

15.

Cholangiocarcinoma size on magnetic resonance imaging versus pathologic specimen: Implications for radiation treatment planning.

Tanenbaum DG, Hall WA, Mittal P, Nickleach DC, Mikell JL, Colbert LE, Moreno CC, Squires MH 3rd, Fisher SB, Yu DS, Kooby DA, Maithel SK, Landry JC.

Pract Radiat Oncol. 2016 May-Jun;6(3):201-206. doi: 10.1016/j.prro.2015.10.005. Epub 2015 Oct 22.

PMID:
26979545
16.

Radiotherapy patterns of care in gastric adenocarcinoma: a single institution experience.

Cheng J, Squires MH 3rd, Mikell JL, Fisher SB, Staley CA 3rd, Kooby DA, El-Rayes BF, Curran WJ Jr, Hall WA, Colbert LE, Shelton JW, Maithel SK, Landry J, Yu DS.

J Gastrointest Oncol. 2015 Jun;6(3):247-53. doi: 10.3978/j.issn.2078-6891.2015.026.

17.

High nuclear hypoxia-inducible factor 1 alpha expression is a predictor of distant recurrence in patients with resected pancreatic adenocarcinoma.

Colbert LE, Fisher SB, Balci S, Saka B, Chen Z, Kim S, El-Rayes BF, Adsay NV, Maithel SK, Landry JC, Curran WJ Jr.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):631-9. doi: 10.1016/j.ijrobp.2014.11.004. Epub 2015 Jan 13.

18.

The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma.

Hall WA, Colbert LE, Nickleach D, Switchenko J, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC.

J Gastrointest Oncol. 2014 Apr;5(2):77-85. doi: 10.3978/j.issn.2078-6891.2014.001.

19.

CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer.

Colbert LE, Petrova AV, Fisher SB, Pantazides BG, Madden MZ, Hardy CW, Warren MD, Pan Y, Nagaraju GP, Liu EA, Saka B, Hall WA, Shelton JW, Gandhi K, Pauly R, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS.

Cancer Res. 2014 May 15;74(10):2677-87. doi: 10.1158/0008-5472.CAN-13-1996. Epub 2014 Mar 13.

20.

Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base.

Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC.

Cancer. 2014 Feb 15;120(4):499-506. doi: 10.1002/cncr.28530. Epub 2014 Jan 3.

21.

Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.

Hall WA, Petrova AV, Colbert LE, Hardy CW, Fisher SB, Saka B, Shelton JW, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Volkan Adsay N, Curran WJ, Landry JC, Maithel SK, Yu DS.

Oncogene. 2014 Nov 20;33(47):5450-6. doi: 10.1038/onc.2013.488. Epub 2013 Nov 25.

PMID:
24276239
22.

Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.

Colbert LE, Fisher SB, Hardy CW, Hall WA, Saka B, Shelton JW, Petrova AV, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS.

Cancer. 2013 Sep 1;119(17):3148-55. doi: 10.1002/cncr.28144. Epub 2013 May 29.

23.

The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma.

Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC.

Cancer. 2013 Jun 15;119(12):2350-7. doi: 10.1002/cncr.28047. Epub 2013 Apr 26.

Supplemental Content

Loading ...
Support Center